Bandol (sildenafil oral spray) / Aspargo Labs - LARVOL DELTA

PK and Onset of Hezkue Oral Sildenafil Suspension After Alcohol Consumption (clinicaltrials.gov) - P1 | N=24 | Not yet recruiting | Sponsor: Aspargo Labs, Inc

New P1 trial

Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension (clinicaltrials.gov) - P2 | N=36 | Not yet recruiting | Sponsor: Aspargo Labs, Inc

New P2 trial • Erectile Dysfunction

Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject (clinicaltrials.gov) - P1 | N=72 | Not yet recruiting | Sponsor: Aspargo Labs, Inc | Trial completion date: Nov 2025 ➔ Mar 2026 | Initiation date: Aug 2025 ➔ Jan 2026 | Trial primary completion date: Nov 2025 ➔ Mar 2026

Trial completion date • Trial initiation date • Trial primary completion date • Erectile Dysfunction

The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: Aspargo Labs, Inc | Trial primary completion date: Oct 2025 ➔ Feb 2026

Trial primary completion date • Erectile Dysfunction

ASP-011-SIL: Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction (clinicaltrials.gov) - P2 | N=200 | Not yet recruiting | Sponsor: Aspargo Labs, Inc

New P2 trial • Erectile Dysfunction

Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject (clinicaltrials.gov) - P1 | N=72 | Not yet recruiting | Sponsor: Aspargo Labs, Inc

New P1 trial • Erectile Dysfunction

The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: Aspargo Labs, Inc | Not yet recruiting ➔ Recruiting | Trial completion date: May 2025 ➔ Dec 2025 | Trial primary completion date: Apr 2025 ➔ Oct 2025

Enrollment open • Trial completion date • Trial primary completion date • Erectile Dysfunction

The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 Mg Hezkue® (ASP-001.1, Sildenafil) Under Fed Versus 100 Mg of Hezkue® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: Aspargo Labs, Inc

New P1 trial • Erectile Dysfunction

Study to Compare the Effects of Viagra® Vs Hezkue® in Healthy Fasted Male Participants. (clinicaltrials.gov) - P1 | N=56 | Not yet recruiting | Sponsor: Aspargo Labs, Inc

New P1 trial • Erectile Dysfunction